Use of clot-busting drug for stroke has almost doubled

08/26/2013 | HealthDay News

An analysis of information from almost 1,700 U.S. hospitals found an increase in the use of clot-busting tissue plasminogen activator as a therapy for ischemic stroke, according to a study in the journal Circulation: Cardiovascular Quality and Outcomes. Among patients who were transported to hospitals swiftly and who did not have conditions that could increase the drug's risks, usage grew from 43% in 2003 to 77% in 2011. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity," researcher Dr. Lee Schwamm said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD